Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21


A fatal case of daclizumab-induced liver failure in a patient with MS.

Stettner M, Gross CC, Mausberg AK, Pul R, Junker A, Baba HA, Schulte-Mecklenbeck A, Wiendl H, Kleinschnitz C, Meuth SG.

Neurol Neuroimmunol Neuroinflamm. 2019 Jan 21;6(2):e539. doi: 10.1212/NXI.0000000000000539. eCollection 2019 Mar. No abstract available.


Myelination in Multiple Sclerosis Lesions Is Associated with Regulation of Bone Morphogenetic Protein 4 and Its Antagonist Noggin.

Harnisch K, Teuber-Hanselmann S, Macha N, Mairinger F, Fritsche L, Soub D, Meinl E, Junker A.

Int J Mol Sci. 2019 Jan 3;20(1). pii: E154. doi: 10.3390/ijms20010154.


Liponeurocytoma: Systematic Review of a Rare Entity.

Gembruch O, Junker A, Mönninghoff C, Ahmadipour Y, Darkwah Oppong M, Sure U, El Hindy N, Lemonas E.

World Neurosurg. 2018 Dec;120:214-233. doi: 10.1016/j.wneu.2018.09.001. Epub 2018 Sep 8.


Cerebellar liponeurocytoma - a rare entity: a case report.

Gembruch O, Junker A, Ahmadipour Y, Sure U, Lemonas E.

J Med Case Rep. 2018 Jun 17;12(1):170. doi: 10.1186/s13256-018-1706-z.


Acutely damaged axons are remyelinated in multiple sclerosis and experimental models of demyelination.

Schultz V, van der Meer F, Wrzos C, Scheidt U, Bahn E, Stadelmann C, Brück W, Junker A.

Glia. 2017 Aug;65(8):1350-1360. doi: 10.1002/glia.23167. Epub 2017 May 31.


Expression of the Antioxidative Enzyme Peroxiredoxin 2 in Multiple Sclerosis Lesions in Relation to Inflammation.

Voigt D, Scheidt U, Derfuss T, Brück W, Junker A.

Int J Mol Sci. 2017 Apr 4;18(4). pii: E760. doi: 10.3390/ijms18040760.


Teaching NeuroImages: Sonographic detection of intraneural perineurioma in therapy-refractory carpal tunnel syndrome.

Krogias C, Gold R, Schelle T, Böhm J, Junker A, Sure U, Uerschels AK.

Neurology. 2017 Mar 7;88(10):e85-e86. doi: 10.1212/WNL.0000000000003692. No abstract available.


CTLA4 as Immunological Checkpoint in the Development of Multiple Sclerosis.

Gerdes LA, Held K, Beltrán E, Berking C, Prinz JC, Junker A, Tietze JK, Ertl-Wagner B, Straube A, Kümpfel T, Dornmair K, Hohlfeld R.

Ann Neurol. 2016 Aug;80(2):294-300. doi: 10.1002/ana.24715. Epub 2016 Jul 15.


Brain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?

Abdelhak A, Junker A, Brettschneider J, Kassubek J, Ludolph AC, Otto M, Tumani H.

Int J Mol Sci. 2015 Jul 31;16(8):17565-88. doi: 10.3390/ijms160817565. Review.


Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination.

Mohan H, Friese A, Albrecht S, Krumbholz M, Elliott CL, Arthur A, Menon R, Farina C, Junker A, Stadelmann C, Barnett SC, Huitinga I, Wekerle H, Hohlfeld R, Lassmann H, Kuhlmann T, Linington C, Meinl E.

Acta Neuropathol Commun. 2014 Dec 11;2:168. doi: 10.1186/s40478-014-0168-9.


Autoinflammatory grey matter lesions in humans: cortical encephalitis, clinical disorders, experimental models.

Junker A, Brück W.

Curr Opin Neurol. 2012 Jun;25(3):349-57. doi: 10.1097/WCO.0b013e3283534a8a. Review.


MicroRNA regulation in experimental autoimmune encephalomyelitis in mice and marmosets resembles regulation in human multiple sclerosis lesions.

Lescher J, Paap F, Schultz V, Redenbach L, Scheidt U, Rosewich H, Nessler S, Fuchs E, Gärtner J, Brück W, Junker A.

J Neuroimmunol. 2012 May 15;246(1-2):27-33. doi: 10.1016/j.jneuroim.2012.02.012. Epub 2012 Mar 22.


Prospects of transcript profiling for mRNAs and MicroRNAs using formalin-fixed and paraffin-embedded dissected autoptic multiple sclerosis lesions.

Eisele S, Krumbholz M, Fischer MT, Mohan H, Junker A, Arzberger T, Hohlfeld R, Bradl M, Lassmann H, Meinl E.

Brain Pathol. 2012 Sep;22(5):607-18. doi: 10.1111/j.1750-3639.2012.00564.x. Epub 2012 Feb 13.


Epstein-Barr virus in the multiple sclerosis brain: a controversial issue--report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria.

Lassmann H, Niedobitek G, Aloisi F, Middeldorp JM; NeuroproMiSe EBV Working Group.

Brain. 2011 Sep;134(Pt 9):2772-86. doi: 10.1093/brain/awr197. Epub 2011 Aug 16.


Expression of herpes simplex virus 1-encoded microRNAs in human trigeminal ganglia and their relation to local T-cell infiltrates.

Held K, Junker A, Dornmair K, Meinl E, Sinicina I, Brandt T, Theil D, Derfuss T.

J Virol. 2011 Oct;85(19):9680-5. doi: 10.1128/JVI.00874-11. Epub 2011 Jul 27.


Pathophysiology of translational regulation by microRNAs in multiple sclerosis.

Junker A.

FEBS Lett. 2011 Dec 1;585(23):3738-46. doi: 10.1016/j.febslet.2011.03.052. Epub 2011 Mar 29. Review.


The emerging role of microRNAs in multiple sclerosis.

Junker A, Hohlfeld R, Meinl E.

Nat Rev Neurol. 2011 Jan;7(1):56-9. doi: 10.1038/nrneurol.2010.179. Epub 2010 Dec 14. Review.


Extracellular matrix in multiple sclerosis lesions: Fibrillar collagens, biglycan and decorin are upregulated and associated with infiltrating immune cells.

Mohan H, Krumbholz M, Sharma R, Eisele S, Junker A, Sixt M, Newcombe J, Wekerle H, Hohlfeld R, Lassmann H, Meinl E.

Brain Pathol. 2010 Sep;20(5):966-75. doi: 10.1111/j.1750-3639.2010.00399.x. Epub 2010 Mar 25.


MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47.

Junker A, Krumbholz M, Eisele S, Mohan H, Augstein F, Bittner R, Lassmann H, Wekerle H, Hohlfeld R, Meinl E.

Brain. 2009 Dec;132(Pt 12):3342-52. doi: 10.1093/brain/awp300.


Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis.

Meinl E, Krumbholz M, Derfuss T, Junker A, Hohlfeld R.

J Neurol Sci. 2008 Nov 15;274(1-2):42-4. doi: 10.1016/j.jns.2008.06.032. Epub 2008 Aug 19. Review.


Supplemental Content

Loading ...
Support Center